Hodgkin's Lymphoma

As per available reports about 36 journals, 240 Conferences are presently dedicated exclusively to Hodgkin's lymphomaand about 51797 articles are being published on the current trends in Hodgkin's lymphoma. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to proteomics are being carried out. Hodgkin's lymphoma is a type of lymphoma, which is a cancer originating from white blood cells called lymphocytes. Hodgkin lymphoma may be treated with radiation therapy, chemotherapy, or hematopoietic stem cell transplantation, with the choice of treatment depending on the age and sex of the patient and the stage, bulk, and histological subtype of the disease.

The Journal of Blood Disorders & Transfusionis an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Hodgkin's lymphoma. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Blood Disorders & Transfusion provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Hodgkin's lymphoma and bioinformatics, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences. OMICS Group Internationalaims to disseminate knowledge with the help of its Open access Journals and marches on to instigate OMICS Group International Conferences in the year 2010, to provide a meaningful platform for the world renowned scientists, researchers, students, academicians, institutions, entrepreneurs and industries through its scientific events annually throughout the globe.